MoonLake Immunotherapeutics (MLTX)

NASDAQ: MLTX · Delayed Price · USD
-0.30 (-5.67%)
At close: May 23, 2022 4:00 PM
-0.04 (-0.80%)
After-hours:May 23, 2022 5:00 PM EDT
Market Cap184.26M
Revenue (ttm)n/a
Net Income (ttm)-69.45M
Shares Out36.93M
EPS (ttm)-0.31
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Close5.29
Day's Range4.82 - 5.68
52-Week Range4.25 - 15.19
Price Targetn/a
Earnings Daten/a

About MLTX

As of April 5, 2022, Helix Acquisition Corp. was acquired by MoonLake Immunotherapeutics AG, in a reverse merger transaction. Helix Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. The company was founded in 2020 and is based in Boston, Massachusetts.

IndustryShell Companies
CountryUnited States
Stock ExchangeNASDAQ
Ticker SymbolMLTX
Full Company Profile

Financial Performance

Financial Statements


MoonLake Immunotherapeutics starts Phase 2 trial of the Nanobody® Sonelokimab in patients with moderate-to-severe hid...

MoonLake Immunotherapeutics starts Phase 2 trial of the Nanobody® Sonelokimab in patients with moderate-to-severe hidradenitis suppurativa

1 week ago - GlobeNewsWire

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of He...

New York, New York--(Newsfile Corp. - October 4, 2021) -  The following statement is being issued by Levi & Korsinsky, LLP:To: All Persons or Entities who purchased Helix Acquisition Corp. (NASDAQ: HLXA...

7 months ago - Newsfile Corp

MoonLake Immunotherapeutics AG and Helix Acquisition Corp. Announce Business Combination Agreement to Create Publicly...

ZUG, Switzerland & BOSTON--(BUSINESS WIRE)--MoonLake Immunotherapeutics AG, a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases and H...

7 months ago - Business Wire

Helix Acquisition Corp. Announces Closing of $115 Million Initial Public Offering, Including the Full Exercise of the...

Boston, Massachusetts--(Newsfile Corp. - October 22, 2020) - Helix Acquisition Corp. (NASDAQ: HLXA) (the "Company") announced today that on Oct. 22, 2020 it closed its initial public offering of 11,500,...

1 year ago - Newsfile Corp

Helix Acquisition Corp. Announces Pricing of $100 Million Initial Public Offering

Boston, Massachusetts--(Newsfile Corp. - October 19, 2020) - Helix Acquisition Corp. (the "Company") announced today that it priced its initial public offering of 10,000,000 Class A ordinary shares at $...

1 year ago - Newsfile Corp